Clive S. Zent | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Clive S. Zent is active.

Explore More

Publication

Featured researches published by Clive S. Zent.

Blood | 2008

Cyclophosphamide Remains An Important Component of Treatment in CLL Patients Receiving Pentostatin and Rituximab Based Chemoimmunotherapy

Neil E. Kay; Wenting Wu; John C. Byrd; Brian Kabat; Diane F. Jelinek; Clive S. Zent; Timothy G. Call; Thomas S. Lin; T. D. Shanafelt

Archive | 2017

Differential expression of microRNAs in transformation of follicular lymphoma to diffuse large B cell lymphoma

Kateřina Musilová; Gabriela Pavlasová; Václav Šeda; Eva Vojáčková; Kateřina Černá; Veronika Svobodová; Robert Pytlik; Vit Prochazka; Zuzana Prouzová; Šárka Pospíšilová; Lenka Zlámalíková; Heidi Mocikova; Lenka Kruzova; Marie Jarosova; Andrew G. Evans; Clive S. Zent; Leoš Křen; Marek Trněný; Jiří Mayer; Andrea Janíková; Marek Mráz

Archive | 2016

The role of microRNA-150 in the prognosis and transformation of follicular lymphoma.

Kateřina Musilová; Gabriela Pavlasová; Václav Šeda; Eva Vojáčková; Kateřina Černá; Jana Didi; Robert Pytlik; Vit Prochazka; Zuzana Ptouzová; Lenka Zlámalíková; Šárka Pospíšilová; Andrew G. Evans; Clive S. Zent; Leoš Křen; Marek Trněný; Jiří Mayer; Andrea Janíková; Marek Mráz

Archive | 2013

cyclophosphamide, and rituximab lymphocytic leukemia patients treated with pentostatin, Mcl-1 expression predicts progression-free survival in chronic

David M. Lucas; Clive S. Zent; Timothy G. Call; Nyla A. Heerema; Gerard Lozanski; John C. Byrd; F. Jelinek; Renee C. Tschumper; Charla Secreto; Thomas S. Lin; Michael R. Grever; T. Awan; Neil E. Kay; Melanie E. Davis; Wenting Wu; Susan Geyer; Nelson Leung

Archive | 2012

Inhibice adheze závislé na integrinech jako přístup pro překonání rezistence k rituximabu u b-buněčných lymfomů.

Marek Mráz; Clive S. Zent; Amy K. Church; Diane F. Jelinek; Jiří Mayer; Šárka Pospíšilová; Dáša Bohačiaková; S M Ansell; Anne J. Novak; Thomas E. Witzig; Grzegorz S. Nowakowski

Archive | 2011

Stromální buňky chrání maligní B-lymfocyty před rituximabemindukovanou apoptózou a inhibice integrinu alfa-4-beta-1(VLA-4) umožňuje překonat tuto rezistenci

Marek Mráz; Clive S. Zent; Amy K. Church; Diane F. Jelinek; Jiří Mayer; Šárka Pospíšilová; S M Ansell; Anne J. Novak; Thomas E. Witzig; Grzegorz S. Nowakowski

Archive | 2010

Targeting integrin/CD49D/VLA-4 with natalizumab can inhibitadhesion of malignant B cells and sensitize them tochemoimmunotherapy

Marek Mráz; Clive S. Zent; Amy K. Church; Diane F. Jelinek; Šárka Pospíšilová; S M Ansell; Anne J. Novak; Thomas E. Witzig; Grzegorz S. Nowakowski

Blood | 2008

Mcl-1 as a Possible Predictor of Progression-Free Survival in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Pentostatin, Cyclophosphamide and Rituximab.

Farrukh T. Awan; Neil E. Kay; Melanie E. Davis; Wenting Wu; Nelson Leung; Diane F. Jelinek; Renee Tschumper; Charla Secreto; Thomas S. Lin; Michael R. Grever; T. D. Shanafelt; Clive S. Zent; Timothy G. Call; Nyla A. Heerema; Gerard Lozanski; John C. Byrd; David M. Lucas

Blood | 2007

Deletion 13q in B-CLL: Interphase FISH Reveals More 13q- Than Does CpG Stimulation.

Daniel L. Van Dyke; Gordon W. Dewald; Timothy G. Call; Diane F. Jelinek; Clive S. Zent; Tait D. Shanafelt; Stephanie A. Smoley; Kimberly J. Stockero; Neil E. Kay

Archive | 2006

Short communication Loss of TP53 is due to rearrangements involving chromosome region 17p10~p12 in chronic lymphocytic leukemia

Stephanie R. Fink; Stephanie A. Smoley; Kimberly J. Stockero; Sarah F. Paternoster; Erik C. Thorland; Daniel L. Van Dyke; Tait D. Shanafelt; Clive S. Zent; Timothy G. Call; Neil E. Kay; Gordon W. Dewald

Explore More